Search research articles
Contact Us
Filters
Showing results (281-290 of 291) with videos related to
Page
of 30
Sort By:
American Journal of Medical Genetics. Part A
|
March 29, 2019
Safety of switching to Migalastat from enzyme replacement therapy in Fabry disease: Experience from the Phase 3 ATTRACT study
Derralynn A Hughes, Kathleen Nicholls, Gere Sunder-Plassmann, et al.
Biorxiv : the Preprint Server for Biology
|
July 14, 2025
<i>In vivo</i> production of an anti-HIV antibody from primate hematopoietic cells by non-viral knock-in
Jack M P Castelli, Katrina Poljakov, Youngseo Jwa, et al.
Current Medicinal Chemistry
|
July 19, 2013
The new compound GET73, N-[(4-trifluoromethyl)benzyl]4-methoxybutyramide, Regulates hippocampal Aminoacidergic transmission possibly via an allosteric modulation of mGlu5 receptor. Behavioural evidence of its "anti-alcohol" and anxiolytic properties
L Ferraro, A Loche, S Beggiato, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
February 7, 2019
Efficacy of the pharmacologic chaperone migalastat in a subset of male patients with the classic phenotype of Fabry disease and migalastat-amenable variants: data from the phase 3 randomized, multicenter, double-blind clinical trial and extension study
Dominique P Germain, Kathy Nicholls, Roberto Giugliani, et al.
Gene Therapy
|
January 14, 2026
CRISPR-AuNP: physicochemical optimization of a gold nanoparticle platform for cost-effective and modular non-viral gene editing in HSPCs
Karthikeya S V Gottimukkala, Daniel D Lane, Rachel Cunningham, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
June 4, 2011
Update on emergence of HIV-1 resistance to antiretroviral drug classes in an Italian national database: 2007-2009
S Di Giambenedetto, M Prosperi, I Fanti, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 4, 2026
In vivo production of an anti-HIV antibody in mice by non-viral gene knock-in in primate hematopoietic stem and progenitor cells
Jack M P Castelli, Katrina Poljakov, Youngseo Jwa, et al.
Orphanet Journal of Rare Diseases
|
April 29, 2018
Migalastat improves diarrhea in patients with Fabry disease: clinical-biomarker correlations from the phase 3 FACETS trial
Raphael Schiffmann, Daniel G Bichet, Ana Jovanovic, et al.
Nature Communications
|
July 2, 2024
Cyprocide selectively kills nematodes via cytochrome P450 bioactivation
Jessica Knox, Andrew R Burns, Brittany Cooke, et al.
Science (New York, N.Y.)
|
October 30, 2025
The functional landscape of coding variation in the familial hypercholesterolemia gene <i>LDLR</i>
Daniel R Tabet, Atina G Coté, Megan C Lancaster, et al.
Page
of 30
Search research articles
Search
Showing results (281-290 of 291) with videos related to
Sort By:
Page
of 30
American Journal of Medical Genetics. Part A
|
March 29, 2019
Safety of switching to Migalastat from enzyme replacement therapy in Fabry disease: Experience from the Phase 3 ATTRACT study
Derralynn A Hughes, Kathleen Nicholls, Gere Sunder-Plassmann, et al.
Biorxiv : the Preprint Server for Biology
|
July 14, 2025
<i>In vivo</i> production of an anti-HIV antibody from primate hematopoietic cells by non-viral knock-in
Jack M P Castelli, Katrina Poljakov, Youngseo Jwa, et al.
Current Medicinal Chemistry
|
July 19, 2013
The new compound GET73, N-[(4-trifluoromethyl)benzyl]4-methoxybutyramide, Regulates hippocampal Aminoacidergic transmission possibly via an allosteric modulation of mGlu5 receptor. Behavioural evidence of its "anti-alcohol" and anxiolytic properties
L Ferraro, A Loche, S Beggiato, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
February 7, 2019
Efficacy of the pharmacologic chaperone migalastat in a subset of male patients with the classic phenotype of Fabry disease and migalastat-amenable variants: data from the phase 3 randomized, multicenter, double-blind clinical trial and extension study
Dominique P Germain, Kathy Nicholls, Roberto Giugliani, et al.
Gene Therapy
|
January 14, 2026
CRISPR-AuNP: physicochemical optimization of a gold nanoparticle platform for cost-effective and modular non-viral gene editing in HSPCs
Karthikeya S V Gottimukkala, Daniel D Lane, Rachel Cunningham, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
June 4, 2011
Update on emergence of HIV-1 resistance to antiretroviral drug classes in an Italian national database: 2007-2009
S Di Giambenedetto, M Prosperi, I Fanti, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 4, 2026
In vivo production of an anti-HIV antibody in mice by non-viral gene knock-in in primate hematopoietic stem and progenitor cells
Jack M P Castelli, Katrina Poljakov, Youngseo Jwa, et al.
Orphanet Journal of Rare Diseases
|
April 29, 2018
Migalastat improves diarrhea in patients with Fabry disease: clinical-biomarker correlations from the phase 3 FACETS trial
Raphael Schiffmann, Daniel G Bichet, Ana Jovanovic, et al.
Nature Communications
|
July 2, 2024
Cyprocide selectively kills nematodes via cytochrome P450 bioactivation
Jessica Knox, Andrew R Burns, Brittany Cooke, et al.
Science (New York, N.Y.)
|
October 30, 2025
The functional landscape of coding variation in the familial hypercholesterolemia gene <i>LDLR</i>
Daniel R Tabet, Atina G Coté, Megan C Lancaster, et al.
Page
of 30